Comparison of the antiepileptogenic effects of an early long-term treatment with ethosuximide or levetiracetam in a genetic animal model of absence epilepsy

Epilepsia
Emilio RussoG De Sarro

Abstract

Epilepsy is a heterogeneous syndrome characterized by recurrent, spontaneous seizures; continuous medication is, therefore, necessary, even after the seizures have long been suppressed with antiepileptic drug (AED) treatments. The most disturbing issue is the inability of AEDs to provide a persistent cure, because these compounds generally suppress the occurrence of epileptic seizures without necessarily having antiepileptogenic properties. The aim of our experiments was to determine, in the WAG/Rij model of absence epilepsy, if early long-term treatment with some established antiabsence drugs might prevent the development of seizures, and whether such an effect could be sustained. WAG/Rij rats were treated for ∼3.5 months (starting at 1.5 months of age, before seizure onset) with either ethosuximide (ETH; drug of choice for absence epilepsy) or levetiracetam (LEV; a broad-spectrum AED with antiabsence and antiepileptogenic properties). We have demonstrated that both drugs are able to reduce the development of absence seizures, exhibiting antiepileptogenic effects in this specific animal model. These findings suggest that absence epilepsy in this strain of rats very likely follows an epileptogenic process during life and that e...Continue Reading

References

Aug 1, 1989·Neuropharmacology·R KarlerS A Turkanis
Nov 1, 1986·Brain Research·M VergnesJ M Warter
Mar 1, 1995·The European Journal of Neuroscience·K D Micheva, C Beaulieu
May 30, 1998·Journal of Neuroscience Methods·T SaitoT Nemoto
Sep 3, 1998·European Journal of Pharmacology·H KlitgaardE Wülfert
Jul 24, 2001·Seizure : the Journal of the British Epilepsy Association·C ZonaD G Margineanu
Dec 18, 2001·Biopharmaceutics & Drug Disposition·J MifsudW C McRoberts
Mar 7, 2002·Epilepsia·E A LukyanetzP G Kostyuk
Dec 14, 2002·Brain Research. Developmental Brain Research·Laura M RitterJames H Meador-Woodruff
Oct 24, 2003·Behavior Genetics·A M L Coenen, E L J M Van Luijtelaar
Mar 23, 2004·Neuropharmacology·Emilio RussoGiovambattista De Sarro
Jun 15, 2004·Progress in Neurobiology·Kiyoshi MorimotoRonald J Racine
Jun 19, 2004·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·M Strolin BenedettiE Baltes
Jun 24, 2004·Proceedings of the National Academy of Sciences of the United States of America·Berkley A LynchBruno Fuks
Jul 13, 2004·Epilepsy Research·Clementina M van RijnHarry Meinardi
Nov 3, 2004·Seizure : the Journal of the British Epilepsy Association·Brigitte M Bouwman, Clementina M van Rijn
Nov 24, 2005·Epilepsia·Hal Blumenfeld
Feb 21, 2006·Epilepsy Research·Maartje C van de Bovenkamp-JanssenEric W Roubos
May 27, 2006·Neuroscience and Biobehavioral Reviews·Gilles van Luijtelaar, Evgenia Sitnikova
Jun 27, 2006·Journal of Pharmacological Sciences·Masashi Sasa
Jul 6, 2006·The European Journal of Neuroscience·Ulrich SchriddeGilles van Luijtelaar
Nov 18, 2006·Lancet Neurology·Yehezkel Ben-Ari, Gregory L Holmes
Jul 14, 2007·CNS Drug Reviews·M Zafer Gören, Filiz Onat
Jul 17, 2007·Seizure : the Journal of the British Epilepsy Association·Varsha SharmaRameshwar Singh
Jul 17, 2007·Proceedings of the National Academy of Sciences of the United States of America·Xiao-Bo LiuEdward G Jones
Feb 13, 2008·Epilepsia·Erwin A van VlietJan A Gorter

❮ Previous
Next ❯

Citations

Jul 11, 2013·Epilepsy Currents·Jeffrey R Tenney, Tracy A Glauser
Jun 4, 2014·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Emilio RussoGiuseppe Donato
Oct 15, 2014·Experimental Animals·Tadao SerikawaMasashi Sasa
Feb 17, 2017·Neurochemistry International·Tomotaka Tanaka, Masafumi Ihara
Aug 21, 2013·Pharmacological Reports : PR·Krzysztof Sendrowski, Wojciech Sobaniec
Jun 2, 2017·Epilepsy & Behavior : E&B·Navjot KaurRajesh Kumar Goel
Jun 21, 2018·Expert Opinion on Pharmacotherapy·Chiara MazzocchettiAlberto Verrotti
Nov 5, 2014·Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan·Ryuta Koyama
Jan 1, 2010·Acta Crystallographica. Section E, Structure Reports Online·Ignez CaracelliEdward R T Tiekink
Sep 21, 2013·Nature Reviews. Drug Discovery·Wolfgang LöscherDieter Schmidt
Jul 10, 2013·British Journal of Clinical Pharmacology·Kim L PowellTerence J O'Brien
Feb 22, 2014·Current Opinion in Neurology·Eugen Trinka, Francesco Brigo
Mar 29, 2014·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Rafal M KaminskiHenrik Klitgaard
Nov 19, 2014·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Rita CitraroGiovambattista De Sarro
Feb 5, 2014·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Asla Pitkänen, Jerome Engel
Aug 7, 2019·Pharmacological Reports : PR·Antonio LeoRita Citraro
Jan 16, 2014·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·H Steve White, Wolfgang Löscher
Jul 19, 2020·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Antonio LeoRita Citraro
Sep 19, 2020·Epilepsia·Yanyan FengFafa Tian
Jun 7, 2013·Expert Review of Neurotherapeutics·Raimondo D'AmbrosioEmilio Perucca
Oct 26, 2016·CNS Drugs·Wolfgang LöscherHenrik Klitgaard
Aug 23, 2017·Expert Opinion on Drug Discovery·Emilio RussoMarco Mula
Aug 28, 2019·Progress in Neurobiology·Ying YuJianxiong Jiang
Jan 30, 2020·Pharmacological Reports : PR·Antonio LeoRita Citraro
Jun 25, 2018·Neurobiology of Disease·Patricia G SalettiAristea S Galanopoulou

❮ Previous
Next ❯

Related Concepts

Related Feeds

Absence Epilepsy

Absence epilepsy is a common seizure disorder in children which can produce chronic psychosocial sequelae. Discover the latest research on absence epilepsies here.